February 2021 - Page 2 of 7 - CannabisNewsWire

TuesdayFeb 23, 2021 4:20 am

420 with CNW — CBD Added to EU Database of Accepted Cosmetic Ingredients

Although cannabidiol (“CBD”) has enjoyed immense popularity in the past couple of years, the hemp extract is still barely regulated in most territories. In the United States, different states have different CBD regulations, and the situation isn’t any different in Europe. However, the European Union has moved a step closer towards standard legislation after CBD was added as a cosmetic ingredient in the EU’s database. The EU’s Directorate-General for Internal Market, Industry, Entrepreneurship, and SMEs added CBD to its CosIng guidelines as a cosmetic ingredient. This revision to the guidelines comes after the Court of Justice of the European Union…

MondayFeb 22, 2021 4:20 pm

420 with CNW — The Reddit Effect Takes Marijuana Stocks to a New High

Marijuana stocks are the latest stocks to experience the brief high driven by exposure on Reddit. This year, social media has demonstrated that it can be a powerful driver of retail, which has left analysts and investors wondering which company may be the next GameStop (NYSE: GME) According to data provided by Quiver Quantitative, three of the five most-discussed companies on the r/WallStreetBets group on Reddit last week were marijuana stocks, which would explain why the focus moved to marijuana stocks. According to Vanda Research, money followed shortly after, with retail investors pouring in ore than $440 million into marijuana…

MondayFeb 22, 2021 3:16 pm

Cannabis Entrepreneurs and Investors to Participate in the Benzinga Cannabis Capital Conference February 2021

Entrepreneurs and investors gather for Benzinga’s Cannabis Capital Conference on February 25-26, 2021 75+ speakers, featuring cannabis industry pioneers, innovators, and heavy weights Global attendees include leading executives, investors, traders, and shareholders interested in the cannabis sector Despite the surging COVID-19 pandemic, the cannabis industry has emerged as an extremely resilient market. Continued legalization of both medical and recreational marijuana in the U.S. and abroad is expected to propel the industry to new heights. Global markets are still developing, and the next five years should offer substantial expansion around the world. While there may well be further market gyrations, there’s…

MondayFeb 22, 2021 12:48 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advances Rapid COVID Test System, Expands Psychedelic Medicine Programs

Life sciences industry accelerator XPhyto Therapeutics Corp. has developed a timeline for the approval and rollout of a rapid, portable COVID-19 test it expects to become available by April in Europe XPhyto’s Covid-ID Lab system is designed to help industries economically devastated by the pandemic to form strategies based on quick and accurate testing, particularly the travel industry The company intends to use its test tech partnership with Germany’s 3a-diagnostics GmbH to build additional bacteriological and viral testing products A separate subsidiary based in Alberta is developing psychedelic medicine programs The subsidiary recently announced it has added mescaline production to…

MondayFeb 22, 2021 12:15 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) Closer to Pure Mushrooms Sales with Company Code, NPN Submission

PULL recently received Company Code from Canada’s Natural and Non-prescription Health Products Directorate Code allows PULL to submit application to sell its first functional mushroom product Company intends to submit additional NPN applications during 2021 as part of larger strategy to develop portfolio of functional mushroom wellness products Functional mushrooms, those that provide a health benefit beyond just nutrition, are growing in popularity worldwide amid an accelerating trend to fend off viruses with immune-boosting food and drinks. Looking to seize part of a global functional mushroom market forecast by Data Bridge Market Research to hit $555.9 billion by 2028, Pure…

MondayFeb 22, 2021 4:20 am

420 with CNW — Medical Marijuana Shares Off to a Great Start on London Stock Exchange

Marijuana shares in the UK have been rising quickly, with investors now looking toward a new investment class in the market: medical marijuana shares. Last week, MGC Pharma, which is London’s first marijuana stock, debuted on the London Stock Exchange. The firm raised £6.5 million ($9 million) on its premiere, with the stock moving to 4.25p (59 cents) a share from a 1.475p (25 cents) per share opening price. This left the company with a market cap of more than £75 million ($104 million). In a way, the increase in the London stock mirrored the American market, when investors from…

FridayFeb 19, 2021 4:20 pm

420 with CNW — Why Cannabis Concentrate Sales Are Booming

Despite a pandemic ravaging the global economy last year, the cannabis industry survived relatively unscathed. In most states where legal marijuana markets categorized the controversial crop as essential, cannabis sellers were allowed to continue their operations amid lockdown orders. But while cannabis flower enjoyed consistently high sales numbers, cannabis concentrates were also carving out a market for themselves. Comparing sales data collected from January to November 2020 to data collected over the same period the year before, data analytics firm Headset found that there was a 40% surge in marijuana concentrate sales in states such as Colorado, Nevada, California and…

FridayFeb 19, 2021 11:38 am

Ryah Group Inc. Making Digital Transformation in the Lab a Reality

Company has completed steps necessary to achieve, sustain competitive advantage in move towards remote-health solutions and trials RYAH technology optimizes patient feedback so medical trials, studies can move into remote solution zones Recently developed an integrated, customized mobile application to support a major clinical study in the United Kingdom RYAH created cloud of stored data to help with R&D of future medical treatments RYAH Group, a leading digital health-care analytics and technology company, is on a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. The company believes that, when patients are given more…

FridayFeb 19, 2021 10:46 am

CannAssist International Corp. (CNSC) Sees Product Popularity Grow as Professional Athletes Switch to CBD for Pain Relief

CBD-based products have become increasingly popular among professional athletes, primarily due to pain-relieving, anti-inflammatory qualities CannAssist International's Xceptor Labs is an active player within the CBD-based product sector through the development of its proprietary CiBiDinol technology CiBiDinol's technology, using a water-soluble carrier, developed an encapsulation process to deliver unchanged CBD molecule through cell's watery matrix Xceptor Labs has seen rapid uptake in products' popularity, with ten products now available for sale online When three-time National Football League tight end Rob Gronkowski first announced his retirement from professional football, he attributed part of the decision to the heavy toll that injuries and…

FridayFeb 19, 2021 10:12 am

Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Is ‘One to Watch’

Golden Leaf Holdings Ltd. is licensed in Oregon and Nevada, with partnerships in manufacturing and distribution in California The Chalice Brands offer full lines of cannabis products grown organically and by local growers The company offers production, processing, wholesale distribution and retail operations within the cannabis industry Golden Leaf Holdings reported sales growth during the pandemic, recording revenue of $6.2 million in Q3 2020, an increase of 42% from Q3 2019. At the end of the third quarter, the company had exceeded total fiscal 2019 revenues The cannabis market is forecast to achieve a CAGR of 18.1%, climbing to a…